Trial · NCT02234583
Results by group92
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 92
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg QD Modal | Baseline | 4.77 | Standard Deviation 2.23 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg BID Modal | Baseline | 5.58 | Standard Deviation 2.22 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg QD Modal | Baseline | 7.08 | Standard Deviation 1.40 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg BID Modal | Baseline | 7.38 | Standard Deviation 1.37 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg QD Modal | Week 13 | 3.47 | Standard Deviation 2.11 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg BID Modal | Week 13 | 4.36 | Standard Deviation 2.32 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg QD Modal | Week 13 | 3.21 | Standard Deviation 2.20 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg BID Modal | Week 13 | 4.06 | Standard Deviation 2.37 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg QD Modal | Week 24 | 3.28 | Standard Deviation 2.08 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg BID Modal | Week 24 | 4.24 | Standard Deviation 2.35 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg QD Modal | Week 24 | 3.0 | Standard Deviation 2.14 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg BID Modal | Week 24 | 4.0 | Standard Deviation 2.38 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg QD Modal | Week 36 | 3.20 | Standard Deviation 2.06 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg BID Modal | Week 36 | 4.25 | Standard Deviation 2.34 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg QD Modal | Week 36 | 2.74 | Standard Deviation 2.23 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg BID Modal | Week 36 | 3.95 | Standard Deviation 2.59 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg QD Modal | Week 48 | 3.22 | Standard Deviation 2.16 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | Rollover DS-5565 15 mg BID Modal | Week 48 | 4.25 | Standard Deviation 2.37 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg QD Modal | Week 48 | 2.46 | Standard Deviation 2.15 | score on a scale |
| Average Daily Pain Score (ADPS) for DS-5565 | De Novo DS-5565 15 mg BID Modal | Week 48 | 3.80 | Standard Deviation 2.61 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02234583/results